177 related articles for article (PubMed ID: 34799779)
1. Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression.
Zinellu A; Paliogiannis P; Carru C; Mangoni AA
Clin Exp Med; 2022 Nov; 22(4):499-508. PubMed ID: 34799779
[TBL] [Abstract][Full Text] [Related]
2. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
Zinellu A; Mangoni AA
Front Immunol; 2021; 12():696085. PubMed ID: 34163491
[TBL] [Abstract][Full Text] [Related]
3. Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression.
Zinellu A; Sotgia S; Fois AG; Mangoni AA
Adv Med Sci; 2021 Sep; 66(2):304-314. PubMed ID: 34256241
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis.
Zinellu A; Mangoni AA
J Nephrol; 2022 Jan; 35(1):59-68. PubMed ID: 34390479
[TBL] [Abstract][Full Text] [Related]
5. B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
Zinellu A; Sotgia S; Carru C; Mangoni AA
Front Cardiovasc Med; 2021; 8():690790. PubMed ID: 34250044
[TBL] [Abstract][Full Text] [Related]
6. INR and COVID-19 severity and mortality: A systematic review with meta-analysis and meta-regression.
Zinellu A; Paliogiannis P; Carru C; Mangoni AA
Adv Med Sci; 2021 Sep; 66(2):372-380. PubMed ID: 34315012
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol and Triglyceride Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
Zinellu A; Paliogiannis P; Fois AG; Solidoro P; Carru C; Mangoni AA
Front Public Health; 2021; 9():705916. PubMed ID: 34490188
[TBL] [Abstract][Full Text] [Related]
8. Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19.
Liu Z; Li J; Li M; Chen S; Gao R; Zeng G; Chen D; Wang S; Li Q; Hu D; Zeng W; Guo L; Wu X
ESC Heart Fail; 2021 Feb; 8(1):644-651. PubMed ID: 33336560
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammation index, disease severity, and mortality in patients with COVID-19: a systematic review and meta-analysis.
Mangoni AA; Zinellu A
Front Immunol; 2023; 14():1212998. PubMed ID: 37415980
[TBL] [Abstract][Full Text] [Related]
10. Serum Prealbumin Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis.
Zinellu A; Mangoni AA
Front Med (Lausanne); 2021; 8():638529. PubMed ID: 33575267
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis.
Zinellu A; Paliogiannis P; Carru C; Mangoni AA
Int J Infect Dis; 2021 Apr; 105():668-674. PubMed ID: 33737133
[TBL] [Abstract][Full Text] [Related]
12. Red Blood Cell Distribution Width, Disease Severity, and Mortality in Hospitalized Patients with SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
Zinellu A; Mangoni AA
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33466770
[TBL] [Abstract][Full Text] [Related]
13. Features of α-HBDH in COVID-19 patients: A cohort study.
Zhu H; Qu G; Yu H; Huang G; Chen L; Zhang M; Wan S; Pei B
J Clin Lab Anal; 2021 Jan; 35(1):e23690. PubMed ID: 33372716
[TBL] [Abstract][Full Text] [Related]
14. Serum hydroxybutyrate dehydrogenase as an early predictive marker of the severity of acute pancreatitis: a retrospective study.
Xiao W; Liu W; Yin L; Li Y; Lu G; Liu X; Gong W; Ding Y; Wang M; Yan Z
BMC Gastroenterol; 2020 Nov; 20(1):393. PubMed ID: 33218299
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates.
Wang Y; Hao Y; Hu M; Wang Y; Yang H
Int Immunopharmacol; 2022 Oct; 111():109088. PubMed ID: 35921779
[TBL] [Abstract][Full Text] [Related]
16. D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis.
Paliogiannis P; Mangoni AA; Dettori P; Nasrallah GK; Pintus G; Zinellu A
Front Public Health; 2020; 8():432. PubMed ID: 32903841
[TBL] [Abstract][Full Text] [Related]
17. Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injury.
Yu H; Han H; Li J; Li D; Jiang L
Int Immunopharmacol; 2019 Dec; 77():105922. PubMed ID: 31669891
[TBL] [Abstract][Full Text] [Related]
18. Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Zhu Z; Wang M; Lin W; Cai Q; Zhang L; Chen D; Liu F; Xiong X; Chu J; Peng J; Chen K
Immun Inflamm Dis; 2021 Dec; 9(4):1071-1100. PubMed ID: 34405950
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: A systematic review and meta-analysis of observational studies.
Yuan Q; Xing X; Lu Z; Li X
Semin Arthritis Rheum; 2020 Oct; 50(5):1022-1039. PubMed ID: 32911280
[TBL] [Abstract][Full Text] [Related]
20. The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates.
Li S; Ren J; Hou H; Han X; Xu J; Duan G; Wang Y; Yang H
Neurol Sci; 2022 Jul; 43(7):4049-4059. PubMed ID: 35325320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
